Weight-loss medications like Ozempic and Wegovy became household names a few years ago when celebrities began using them. Now, a new trend has stepped into the spotlight: microdosing GLP-1 drugs to ...

The once-daily oral GLP-1 RA orforglipron produces clinically and statistically significant weight loss and cardiometabolic improvements, with safety comparable to that of injectable agents.

Eli Lilly’s weight-loss pill orforglipron shows major success in Phase 3 trial, helping patients lose up to 12 kg. If ...

Eggs are rich in protein, vitamins and minerals, and they're very filling, which makes them a great weight-loss food.

WHO is set to recommend weight-loss drugs like Wegovy, Ozempic, and Mounjaro for adults with obesity, calling it a serious ...

A study finds a modified alternate-day fasting diet more effective for blood pressure control than other low-calorie dietary ...

The World Health Organization (WHO) now supports the use of GLP-1 drugs like semaglutide (Ozempic, Wegovy) for long-term ...

Total spending on GLP-1 receptor agonists in the U.S. increased by over 500% from 2018 to 2023, while it’s projected that anti-obesity revenues will exceed $100 billion by 2030. And with the number of ...

Continuous glucose monitors are trending for people without diabetes. Should you wear a CGM and can it help you lose weight?

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be ...

Jacksonville, United States, September 12, 2025 -- Physician Guided Weight Loss Clinic & RSLV Aesthetics in Jacksonville, FL ...

"I'm upping my dose a little because I want to be extra-snatched," the model said of her Maxim shoot in a clip from her ...